Daniel has a decade of experience as an analyst in the biopharma industry, spanning roles in drug discovery, market analysis, competitive intelligence, and strategic consulting. He now develops and leads Informa Pharma Intelligence’s thought leadership program, producing materials that help clients across a range of hot topics in the biopharma industry, most recently including COVID-19, immuno-oncology, tumor-agnostic drug development, artificial intelligence and M&A.
As part of this, Daniel regularly participates in webinars, conferences and other speaking arrangements, and he is featured across leading publications such as Nature Reviews Drug Discovery, Fortune, Scientific American, Scrip, In Vivo and Vice. Prior to joining Informa, Daniel worked as a medicinal chemist at the UK biotech company Summit Therapeutics and graduated with First Class Honours in Natural Sciences from the University of Bath.
Stephanie Yip joined Informa Pharma Intelligence in 2017. As a Principal Analyst, she is experienced in conducting primary research involving key opinion leaders and payers, analyzing treatment landscapes, and tracking market-moving events to build robust forecasts. Stephanie has produced disease content spanning diverse therapy areas including neurology, psychiatry, immunology & inflammation, gynecology,
and rare diseases. As part of her role, she has worked on consulting projects, such as market opportunity assessments, covered medical conferences, and authored white papers covering hot topics in the pharmaceutical industry. Prior to working at Informa, Stephanie gained experience as an editorial assistant in scientific publishing. She graduated from Imperial College London with a Biomedical Science degree.
Derek Burkhard is responsible for providing insights and analytics on financial content across the pharmaceutical industry for Informa’s Pharma Intelligence division. His team leads the forecasting efforts across Datamonitor Healthcare, including both patient-based and sales-based forecasting methods. The financial team is also responsible for gathering and analyzing company-reported product sales
data,distilling trends across therapy areas and geographies. Prior to working at Informa, Derek spent six years in investment management. He graduated from University of Southern California with a Master of Business Administration and completed his undergraduate education at University of California, San Diego.